Northern Trust
ELAN icon

Northern Trust’s Elanco Animal Health ELAN Stock Holding History

Northern Trust’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$100M Buy
4,189,189
+80,281
+2% +$1.96M 0.01% 739
2025
Q4 		$93M Sell
4,108,908
-182,710
-4% -$3.98M 0.01% 773
2025
Q3 		$86.4M Buy
4,291,618
+1,391,697
+48% +$23.3M 0.01% 806
2025
Q2 		$41.4M Sell
2,899,921
-15,769
-0.5% -$184K 0.01% 1218
2025
Q1 		$30.6M Sell
2,915,690
-27,996
-1% -$317K ﹤0.01% 1375
2024
Q4 		$35.6M Buy
2,943,686
+541,341
+23% +$7.08M 0.01% 1337
2024
Q3 		$35.3M Sell
2,402,345
-31,960
-1% -$445K 0.01% 1269
2024
Q2 		$35.1M Buy
2,434,305
+85,109
+4% +$1.36M 0.01% 1204
2024
Q1 		$38.2M Sell
2,349,196
-103,884
-4% -$1.62M 0.01% 1165
2023
Q4 		$36.6M Buy
2,453,080
+93,203
+4% +$1.06M 0.01% 1234
2023
Q3 		$26.5M Sell
2,359,877
-115,196
-5% -$1.34M 0.01% 1355
2023
Q2 		$24.9M Sell
2,475,073
-260,309
-10% -$2.42M ﹤0.01% 1445
2023
Q1 		$25.7M Sell
2,735,382
-9,096
-0.3% -$107K 0.01% 1390
2022
Q4 		$33.5M Sell
2,744,478
-226,763
-8% -$2.83M 0.01% 1188
2022
Q3 		$36.9M Sell
2,971,241
-146,999
-5% -$2.57M 0.01% 1044
2022
Q2 		$61.2M Sell
3,118,240
-19,486
-0.6% -$461K 0.01% 772
2022
Q1 		$81.9M Buy
3,137,726
+10,527
+0.3% +$280K 0.01% 721
2021
Q4 		$88.7M Sell
3,127,199
-252,011
-7% -$7.84M 0.01% 725
2021
Q3 		$108M Buy
3,379,210
+309,950
+10% +$10.4M 0.02% 625
2021
Q2 		$106M Sell
3,069,260
-211,746
-6% -$6.98M 0.02% 649
2021
Q1 		$96.6M Buy
3,281,006
+104,481
+3% +$3.21M 0.02% 684
2020
Q4 		$97.4M Buy
3,176,525
+460,848
+17% +$14.1M 0.02% 651
2020
Q3 		$75.8M Sell
2,715,677
-251,873
-8% -$6.38M 0.02% 678
2020
Q2 		$63.7M Buy
2,967,550
+290,521
+11% +$6.42M 0.02% 728
2020
Q1 		$59.9M Sell
2,677,029
-252,758
-9% -$6.92M 0.02% 678
2019
Q4 		$86.3M Sell
2,929,787
-69,003
-2% -$1.87M 0.02% 653
2019
Q3 		$79.7M Buy
2,998,790
+302,222
+11% +$9.07M 0.02% 661
2019
Q2 		$91.1M Buy
2,696,568
+473,967
+21% +$15.4M 0.02% 614
2019
Q1 		$71.3M Buy
2,222,601
+1,948,662
+711% +$60M 0.02% 711
2018
Q4 		$8.64M Buy
+273,939
New +$8.97M ﹤0.01% 2183

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Northern Trust's ELAN Position: Q1 2026 in Review

Northern Trust increased its Elanco Animal Health (ELAN) stake by 2% in Q1 2026, buying an estimated $1.96M and bringing the position to 4,189,189 shares worth $100M. The position accounts for 0.01% of the portfolio, ranked #739.

Northern Trust first reported a position in ELAN in Q4 2018 and has held it in 30 quarters since. The position peaked at $108M in Q3 2021. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Northern Trust held 4,189,189 shares of Elanco Animal Health worth $100M as of Q1 2026.
  • Northern Trust bought 80,281 Elanco Animal Health shares in Q1 2026, an estimated $1.96M.
  • Elanco Animal Health made up 0.01% of Northern Trust's portfolio in Q1 2026, its #739 holding.
  • Northern Trust first reported a position in Elanco Animal Health in Q4 2018 and has held it in 30 quarters since.
  • Northern Trust's Elanco Animal Health position peaked at $108M in Q3 2021.
  • 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.